Statistics for Renalytix AI (id:3923 RENX)

Valuation metrics

Market cap

25.86M

Enterprise value

13.18M

Trailing P/E (ttm)

-25.00

Forward P/E

-0.86

PEG ratio

-0.86

Price/Sales (ttm)

11.30

Price/Book (mrq)

Enterprise Value/Revenue

7.30

Enterprise Value/EBITDA

-0.58

Overview

Shares outstanding

333.64M

Float

123.37M

Shares short

% Held by insiders

0.28%

% Held by institutions

0.33%

Average volume (10 days)

188.77K

Average volume (90 days)

Price summary

52-Week low

7.00

52-Week high

74.90

52-Week change

-170.97%

Beta

2.07

50-Day moving average

8.35

200-Day moving average

18.59

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

June 30th, 2024

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

6.82%

Operating margin

-942.83%

Operational effectiveness

Return on assets

-93.54%

Return on equity

425.97%

Income statement

Revenue (ttm)

0.02

Revenue per share (ttm)

0.02

Quarterly revenue growth (yoy)

Gross profit (ttm)

156.00K

EBITDA

-22,571,665.00

Net income to common (ttm)

-26,384,739.00

Diluted EPS (ttm)

-0.24

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

3.69M

Total cash per share (mrq)

0.03

Total debt (mrq)

6.73M

Total Debt/Equity (mrq)

-0.86

Current ratio (mrq)

53.20%

Book value per share (mrq)

-0.05

Cash flow

Cash flow statement

-23,746,739.00

Levered free cash flow (LFCF)

-15,357,284.00